• Je něco špatně v tomto záznamu ?

Use of levothyroxine for euthyroid, thyroid antibody positive women with infertility: Analyses of aggregate data from a survey of European thyroid specialists (Treatment of Hypothyroidism in Europe by Specialists: An International Survey)

R. Negro, M. Žarković, R. Attanasio, L. Hegedüs, EV. Nagy, E. Papini, E. Akarsu, M. Alevizaki, G. Ayvaz, T. Bednarczuk, BN. Beleslin, E. Berta, M. Bodor, AM. Borissova, M. Boyanov, C. Buffet, MC. Burlacu, J. Ćirić, CA. Cohen, JJ. Díez, H. Dobnig,...

. 2024 ; 101 (2) : 180-190. [pub] 20240610

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24019545

OBJECTIVES: The use of levothyroxine (LT4) treatment aiming to improve fertility in euthyroid women with positive thyroid peroxidase antibodies (TPOAb) is not supported by the available evidence. The aim of the study was to document the use of LT4 by European thyroid specialists in such patients. DESIGN: The data presented derive from Treatment of Hypothyroidism in Europe by Specialists, an International Survey (THESIS), a questionnaire conducted between 2019 and 2021 to document the management of hypothyroidism by European thyroid specialists. Here, we report the aggregate results on the use of LT4 in infertile, euthyroid women with positive TPOAb. RESULTS: A total of 2316/5406 (42.8%) respondents stated that LT4 may be indicated in TPOAb positive euthyroid women with infertility. The proportion of those replying positively to this question varied widely across different countries (median 39.4, range 22.9%-83.7%). In multivariate analyses males (OR: 0.8; CI: 0.7-0.9) and respondents >60 years (OR: 0.7; 0.6-0.8) were the least inclined to consider LT4 for this indication. Conversely, respondents managing many thyroid patients ("weekly" [OR: 1.4; CI: 1.0-1.9], "daily" [OR: 1.8; CI: 1.3-2.4]) and practicing in Eastern Europe (OR: 1.5; CI: 1.3-1.9) were most likely to consider LT4. CONCLUSIONS: A remarkably high number of respondents surveyed between 2019 and 2021, would consider LT4 treatment in TPOAb positive euthyroid women with infertility. This view varied widely across countries and correlated with sex, age and workload, potentially influencing patient management. These results raise concerns about potential risks of overtreatment.

3rd Department of Medicine 1st Faculty of Medicine General University Hospital Charles University Prague Czech Republic

5th Department of Internal Medicine Medical Faculty of Comenius University and University Hospital Bratislava Slovakia

5th Medical Department Division of Endocrinology and Diabetes Medical Faculty Mannheim Heidelberg University Mannheim Germany

Cabinet Médical 2 rue Bellefontaine Lausanne Switzerland

Clinic of Endocrinology and Metabolism Medical Faculty University Hospital Sofiamed Sofia University Saint Kliment Ohridski Sofia Bulgaria

Department of Clinical Therapeutics School of Medicine Endocrine Unit and Diabetes Centre Alexandra Hospital National and Kapodistrian University of Athens Athens Greece

Department of Endocrinology and Metabolism Amsterdam UMC University of Amsterdam Amsterdam The Netherlands

Department of Endocrinology and Metabolism Koru Ankara Hospital Ankara Turkey

Department of Endocrinology and Metabolism Regina Apostolorum Hospital Albano Laziale Rome Italy

Department of Endocrinology and Nutrition Université Catholique de Louvain Brussels Belgium

Department of Endocrinology Belarusian State Medical University Minsk Republic of Belarus

Department of Endocrinology Carol Davila University of Medicine and Pharmacy Bucharest Romania

Department of Endocrinology Clínica Universidad de Navarra Pamplona Spain Instituto de Investigación Sanitaria de Navarra Pamplona Spain

Department of Endocrinology Diabetes and Metabolic Diseases Mladen Sekso University Hospital Center Sisters of Mercy Zagreb Croatia

Department of Endocrinology Diabetes and Metabolism Medical Faculty University of Coimbra Coimbra Portugal

Department of Endocrinology Diabetes and Metabolism University Hospital Essen University Duisburg Essen Essen Germany

Department of Endocrinology Diabetes Centre Hellenic Red Cross Hospital Athens Greece

Department of Endocrinology Hospital Universitario Puerta de Hierro Majadahonda Madrid Spain

Department of Endocrinology Metabolism and Internal Medicine Poznan University of Medical Sciences Poznań Poland

Department of Endocrinology No 1 N 5 Sklifosovsky Institute of Clinical Medicine 1 M Sechenov 1st Moscow State Medical University Moscow Russian Federation

Department of Endocrinology Odense University Hospital Odense Denmark

Department of Endocrinology Skåne University Hospital Malmö Sweden

Department of Endocrinology Tampere University Hospital Tampere Finland

Department of Internal Medicine and Endocrinology Medical University of Warsaw Warsaw Poland

Department of Internal Medicine Clinic of Endocrinology and Metabolism University Hospital Alexandrovska Medical University Sofia Sofia Bulgaria

Department of Internal Medicine Division of Endocrinology Faculty of Medicine Gaziantep University Gaziantep Turkey

Department of Internal Medicine Endocrine Unit Brussel Belgium

Department of Internal Medicine Rotterdam Thyroid Center Erasmus Medical Center Rotterdam The Netherlands

Department of Medicine 1 Klinikum Vest GmbH Knappschaftskrankenhaus Recklinghausen Academic Teaching Hospital Ruhr University Bochum Mannheim Germany

Department of Medicine Division of Endocrinology Faculty of Medicine University of Debrecen Debrecen Hungary

Department of Medicine Universidad Autónoma de Madrid Madrid Spain

Department of Reproductive Endocrinology Institute of Endocrinology and Metabolism 5 P Komissarenko National Academy of Medical Science of Ukraine Kyiv Ukraine

Department of Surgery Tampere University Hospital Tampere Finland

Diabetes and Endocrinology Section Beacon Hospital Dublin Ireland

Division of Endocrinology Diabetes and Metabolism University of Lausanne Lausanne Switzerland

Division of Endocrinology Presidio Ospedaliero 5 Fazzi Lecce Italy

East Surrey Hospital Surrey and Sussex Healthcare NHS Trust Redhill Surrey UK

Endocrine Department St Vincent's University Hospital Dublin Ireland

Endocrinology and Metabolism Institute and Davidoff Center Rabin Medical Center Faculty of Medicine Tel Aviv University Petah Tikva Israel

Endocrinology Diabetes and Metabolism Service Centro Hospitalar Universitário de Santo António Porto Portugal

Faculty of Medicine University of Belgrade Belgrade Serbia

Institute of Endocrinology and Metabolism 5 P Komisarenko National Academy of Medical Sciences of Ukraine Kyiv Ukraine

Institute of Translational and Clinical Research Newcastle University Newcastle upon Tyne UK

Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana Majadahonda Spain

Internal Medicine 3 Division of Endocrinology and Metabolism Medical University of Vienna Vienna Austria

Rabin Medical Center Hasharon Campus Petach Tikva Israel

Robert Graves Institute Tallaght University Hospital Dublin Ireland

School of Medicine University College Dublin Dublin Ireland

Scientific Committee Associazione Medici Endocrinologi Milan Italy

Section of Clinical Medicine Faculty of Health and Medical Sciences University of Surrey Guildford Surrey UK

Thyroid and Osteoporosis Praxis Kumberg Austria Thyroid Practice for Radiofrequency Ablation Vienna Austria

Thyroid Diseases and Endocrine Tumor Department GRC 16 Thyroid Tumors APHP Hôpital Pitié Salpêtriére Sorbonne University Paris France

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019545
003      
CZ-PrNML
005      
20241024110805.0
007      
ta
008      
241015s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/cen.15099 $2 doi
035    __
$a (PubMed)38856700
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Negro, Roberto $u Division of Endocrinology, Presidio Ospedaliero "V. Fazzi, Lecce, Italy $1 https://orcid.org/0000000192824530
245    10
$a Use of levothyroxine for euthyroid, thyroid antibody positive women with infertility: Analyses of aggregate data from a survey of European thyroid specialists (Treatment of Hypothyroidism in Europe by Specialists: An International Survey) / $c R. Negro, M. Žarković, R. Attanasio, L. Hegedüs, EV. Nagy, E. Papini, E. Akarsu, M. Alevizaki, G. Ayvaz, T. Bednarczuk, BN. Beleslin, E. Berta, M. Bodor, AM. Borissova, M. Boyanov, C. Buffet, MC. Burlacu, J. Ćirić, CA. Cohen, JJ. Díez, H. Dobnig, V. Fadeyev, BCT. Field, E. Fliers, D. Führer, JC. Galofré, T. Hakala, J. Jan, P. Kopp, M. Krebs, M. Kršek, M. Kužma, L. Leenhardt, V. Luchytskiy, FM. Puga, A. McGowan, M. Melo, S. Metso, C. Moran, T. Morgunova, DA. Niculescu, B. Perić, T. Planck, C. Poiana, E. Robenshtok, PO. Rosselet, M. Ruchala, KR. Riis, A. Shepelkevich, M. Tronko, D. Unuane, I. Vardarli, E. Visser, A. Vryonidou, YR. Younes, P. Perros
520    9_
$a OBJECTIVES: The use of levothyroxine (LT4) treatment aiming to improve fertility in euthyroid women with positive thyroid peroxidase antibodies (TPOAb) is not supported by the available evidence. The aim of the study was to document the use of LT4 by European thyroid specialists in such patients. DESIGN: The data presented derive from Treatment of Hypothyroidism in Europe by Specialists, an International Survey (THESIS), a questionnaire conducted between 2019 and 2021 to document the management of hypothyroidism by European thyroid specialists. Here, we report the aggregate results on the use of LT4 in infertile, euthyroid women with positive TPOAb. RESULTS: A total of 2316/5406 (42.8%) respondents stated that LT4 may be indicated in TPOAb positive euthyroid women with infertility. The proportion of those replying positively to this question varied widely across different countries (median 39.4, range 22.9%-83.7%). In multivariate analyses males (OR: 0.8; CI: 0.7-0.9) and respondents >60 years (OR: 0.7; 0.6-0.8) were the least inclined to consider LT4 for this indication. Conversely, respondents managing many thyroid patients ("weekly" [OR: 1.4; CI: 1.0-1.9], "daily" [OR: 1.8; CI: 1.3-2.4]) and practicing in Eastern Europe (OR: 1.5; CI: 1.3-1.9) were most likely to consider LT4. CONCLUSIONS: A remarkably high number of respondents surveyed between 2019 and 2021, would consider LT4 treatment in TPOAb positive euthyroid women with infertility. This view varied widely across countries and correlated with sex, age and workload, potentially influencing patient management. These results raise concerns about potential risks of overtreatment.
650    _2
$a lidé $7 D006801
650    12
$a thyroxin $x terapeutické užití $7 D013974
650    _2
$a ženské pohlaví $7 D005260
650    12
$a hypotyreóza $x farmakoterapie $x krev $7 D007037
650    _2
$a dospělí $7 D000328
650    12
$a autoprotilátky $x krev $7 D001323
650    12
$a ženská infertilita $x farmakoterapie $7 D007247
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a jodidperoxidasa $x imunologie $7 D007453
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Žarković, Miloš $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia $1 https://orcid.org/0000000199775970
700    1_
$a Attanasio, Roberto $u Scientific Committee, Associazione Medici Endocrinologi, Milan, Italy $1 https://orcid.org/000000021417287X
700    1_
$a Hegedüs, Laszlo $u Department of Endocrinology, Odense University Hospital, Odense, Denmark $1 https://orcid.org/0000000296917619
700    1_
$a Nagy, Endre V $u Department of Medicine, Division of Endocrinology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary $1 https://orcid.org/0000000292866471
700    1_
$a Papini, Enrico $u Department of Endocrinology and Metabolism, Regina Apostolorum Hospital, Albano Laziale, Rome, Italy $1 https://orcid.org/0000000347902733
700    1_
$a Akarsu, Ersin $u Department of Internal Medicine, Division of Endocrinology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey $1 https://orcid.org/0000000327866616
700    1_
$a Alevizaki, Maria $u Department of Clinical Therapeutics, School of Medicine, Endocrine Unit and Diabetes Centre, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece $1 https://orcid.org/0000000337265793
700    1_
$a Ayvaz, Göksun $u Department of Endocrinology and Metabolism, Koru Ankara Hospital, Ankara, Turkey $1 https://orcid.org/0000000212136832
700    1_
$a Bednarczuk, Tomasz $u Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland $1 https://orcid.org/0000000257528709
700    1_
$a Beleslin, Biljana Nedeljković $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia $1 https://orcid.org/0000000216879297
700    1_
$a Berta, Eszter $u Department of Medicine, Division of Endocrinology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary $1 https://orcid.org/0000000304399867
700    1_
$a Bodor, Miklos $u Department of Medicine, Division of Endocrinology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary $1 https://orcid.org/0000000207895156
700    1_
$a Borissova, Anna Maria $u Clinic of Endocrinology and Metabolism, Medical Faculty, University Hospital "Sofiamed", Sofia University "Saint Kliment Ohridski", Sofia, Bulgaria $1 https://orcid.org/000000030553408X
700    1_
$a Boyanov, Mihail $u Department of Internal Medicine, Clinic of Endocrinology and Metabolism, University Hospital "Alexandrovska", Medical University Sofia, Sofia, Bulgaria $1 https://orcid.org/0000000256952831
700    1_
$a Buffet, Camille $u Thyroid Diseases and Endocrine Tumor Department, GRC 16 Thyroid Tumors, APHP, Hôpital Pitié-Salpêtriére, Sorbonne University, Paris, France $1 https://orcid.org/0000000313894157
700    1_
$a Burlacu, Maria-Cristina $u Department of Endocrinology and Nutrition, Université Catholique de Louvain, Brussels, Belgium $1 https://orcid.org/0000000284373933
700    1_
$a Ćirić, Jamina $u Faculty of Medicine, University of Belgrade, Belgrade, Serbia $1 https://orcid.org/0000000169609699
700    1_
$a Cohen, Chagit Adler $u Rabin Medical Center Hasharon Campus, Petach Tikva, Israel
700    1_
$a Díez, Juan J $u Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain $u Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, Majadahonda, Spain $u Department of Medicine, Universidad Autónoma de Madrid, Madrid, Spain $1 https://orcid.org/0000000220170694
700    1_
$a Dobnig, Harald $u Thyroid and Osteoporosis Praxis, Kumberg, Austria, Thyroid Practice for Radiofrequency Ablation, Vienna, Austria $1 https://orcid.org/0000000175749292
700    1_
$a Fadeyev, Valentin $u Department of Endocrinology No. 1, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov 1st Moscow State Medical University, Moscow, Russian Federation $1 https://orcid.org/0000000230266315
700    1_
$a Field, Benjamin C T $u Section of Clinical Medicine, Faculty of Health & Medical Sciences, University of Surrey, Guildford, Surrey, UK $1 https://orcid.org/0000000218831588
700    1_
$a Fliers, Eric $u Department of Endocrinology & Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands $1 https://orcid.org/0000000180489050
700    1_
$a Führer, Dagmar $u Department of Endocrinology, Diabetes and Metabolism, University Hospital Essen, University-Duisburg-Essen, Essen, Germany $1 https://orcid.org/0000000303574192
700    1_
$a Galofré, Juan C $u Department of Endocrinology, Clínica Universidad de Navarra, Pamplona, Spain, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain $1 https://orcid.org/0000000302273566
700    1_
$a Hakala, Tommi $u Department of Surgery, Tampere University Hospital, Tampere, Finland $1 https://orcid.org/0000000293734462
700    1_
$a Jan, Jiskra $u 3rd Department of Medicine, 1st Faculty of Medicine, General University Hospital, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000309204854 $7 xx0061811
700    1_
$a Kopp, Peter $u Division of Endocrinology, Diabetes and Metabolism, University of Lausanne, Lausanne, Switzerland $1 https://orcid.org/0000000159800529
700    1_
$a Krebs, Michael $u Internal Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000292657274
700    1_
$a Kršek, Michal $u 3rd Department of Medicine, 1st Faculty of Medicine, General University Hospital, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000259413489
700    1_
$a Kužma, Martin $u 5th Department of Internal Medicine, Medical Faculty of Comenius University and University Hospital, Bratislava, Slovakia $1 https://orcid.org/0000000212941217
700    1_
$a Leenhardt, Laurence $u Thyroid Diseases and Endocrine Tumor Department, GRC 16 Thyroid Tumors, APHP, Hôpital Pitié-Salpêtriére, Sorbonne University, Paris, France $1 https://orcid.org/0000000341316813
700    1_
$a Luchytskiy, Vitaliy $u Department of Reproductive Endocrinology, Institute of Endocrinology and Metabolism V.P. Komissarenko, National Academy of Medical Science of Ukraine, Kyiv, Ukraine $1 https://orcid.org/0000000235153264
700    1_
$a Puga, Francisca Marques $u Endocrinology, Diabetes and Metabolism Service, Centro Hospitalar Universitário de Santo António, Porto, Portugal $1 https://orcid.org/000000029510419X
700    1_
$a McGowan, Anne $u Robert Graves Institute, Tallaght University Hospital, Dublin, Ireland $1 https://orcid.org/000000034222622X
700    1_
$a Melo, Miguel $u Department of Endocrinology, Diabetes and Metabolism, Medical Faculty, University of Coimbra, Coimbra, Portugal $1 https://orcid.org/0000000283651380
700    1_
$a Metso, Saara $u Department of Endocrinology, Tampere University Hospital, Tampere, Finland $1 https://orcid.org/0000000181977603
700    1_
$a Moran, Carla $u Diabetes & Endocrinology Section, Beacon Hospital, Dublin, Ireland $u Endocrine Department, St Vincent's University Hospital, Dublin, Ireland $u School of Medicine, University College Dublin, Dublin, Ireland $1 https://orcid.org/0000000273187166
700    1_
$a Morgunova, Tatyana $u Department of Endocrinology No. 1, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov 1st Moscow State Medical University, Moscow, Russian Federation $1 https://orcid.org/0000000315001586
700    1_
$a Niculescu, Dan Alexandru $u Department of Endocrinology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania $1 https://orcid.org/0000000264393523
700    1_
$a Perić, Božidar $u Department of Endocrinology, Diabetes and Metabolic Diseases "Mladen Sekso", University Hospital Center "Sisters of Mercy", Zagreb, Croatia $1 https://orcid.org/0000000199984895
700    1_
$a Planck, Tereza $u Department of Endocrinology, Skåne University Hospital, Malmö, Sweden $1 https://orcid.org/0000000313985067
700    1_
$a Poiana, Catalina $u Department of Endocrinology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania $1 https://orcid.org/0000000257953318
700    1_
$a Robenshtok, Eyal $u Endocrinology and Metabolism Institute and Davidoff Center, Rabin Medical Center, Faculty of Medicine, Tel Aviv University, Petah Tikva, Israel $1 https://orcid.org/0000000262684212
700    1_
$a Rosselet, Patrick Olivier $u Cabinet Médical 2, rue Bellefontaine, Lausanne, Switzerland $1 https://orcid.org/0009000437938163
700    1_
$a Ruchala, Marek $u Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznań, Poland $1 https://orcid.org/0000000262967220
700    1_
$a Riis, Kamilla Ryom $u Department of Endocrinology, Odense University Hospital, Odense, Denmark $1 https://orcid.org/0000000326797153
700    1_
$a Shepelkevich, Alla $u Department of Endocrinology, Belarusian State Medical University, Minsk, Republic of Belarus $1 https://orcid.org/0000000282132968
700    1_
$a Tronko, Mykola $u Institute of Endocrinology and Metabolism V.P. Komisarenko, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine $1 https://orcid.org/0000000174210981
700    1_
$a Unuane, David $u Department of Internal Medicine, Endocrine Unit, Brussel, Belgium $1 https://orcid.org/0000000284881735
700    1_
$a Vardarli, Irfan $u Department of Medicine I, Klinikum Vest GmbH, Knappschaftskrankenhaus Recklinghausen, Academic Teaching Hospital, Ruhr-University Bochum, Mannheim, Germany $u 5th Medical Department, Division of Endocrinology and Diabetes, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany $1 https://orcid.org/0009000925540971
700    1_
$a Visser, Edward $u Department of Internal Medicine, Rotterdam Thyroid Center, Erasmus Medical Center, Rotterdam, The Netherlands $1 https://orcid.org/000000025248863X
700    1_
$a Vryonidou, Andromachi $u Department of Endocrinology, Diabetes Centre, Hellenic Red Cross Hospital, Athens, Greece $1 https://orcid.org/0000000205445952
700    1_
$a Younes, Younes R $u East Surrey Hospital, Surrey & Sussex Healthcare NHS Trust, Redhill, Surrey, UK $1 https://orcid.org/0000000309291003
700    1_
$a Perros, Petros $u Institute of Translational and Clinical Research, Newcastle University, Newcastle upon Tyne, UK $1 https://orcid.org/0000000173205574
773    0_
$w MED00009474 $t Clinical endocrinology $x 1365-2265 $g Roč. 101, č. 2 (2024), s. 180-190
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38856700 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024110759 $b ABA008
999    __
$a ok $b bmc $g 2202023 $s 1231518
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 101 $c 2 $d 180-190 $e 20240610 $i 1365-2265 $m Clinical endocrinology $n Clin Endocrinol (Oxf) $x MED00009474
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...